|
|
|
|
Myelodysplastic syndrome
FDA Grants Priority Review for REVLIMID(R) sNDA for Treatment of ... Mar 3, 2006
International News Service, Chromosomal (cytogenetic) abnormalities are detected in more than half of patients with myelodysplastic syndrome (MDS), and involve a deletion in all or part ...
Celgene's Revlimid Has Upside Long-Term Potential Mar 8, 2006
Forbes ...approval in that indication. The drug is currently approved to treat myelodysplastic syndrome, a type of blood cancer. Revlimid, at an ...
Vion Reports 2005 Year-End and Fourth Quarter Financial Results Mar 10, 2006
Webbolt Business News (subscription), ...of Cloretazine(R) (VNP40101M) as a single agent in previously untreated elderly acute myelogenous leukemia and high-risk myelodysplastic syndrome, adult and ...
St. Luke's to host Oncology Nursing Conference Feb 28, 2006
Sioux City Journal, Conference topics will include nursing management of the patient with myelodysplastic syndrome, management of malignant brain tumors, current management of ...
FDA Grants Priority Review for REVLIMID(R) sNDA for Treatment of ... Mar 3, 2006
PR Newswire (press release), Deletion 5q Chromosomal Abnormality Chromosomal (cytogenetic) abnormalities are detected in more than half of patients with myelodysplastic syndrome (MDS), and ...
Telik Announces Initiation of Phase 1-2A Clinical Study of ... Feb 22, 2006
International News Service, ...a multicenter Phase 1-2a clinical study to evaluate the tolerability and pharmcokinetics of TELINTRA(TM) Tablets in patients with myelodysplastic syndrome (MDS ...
Keryx commences phase II trial in leukemia Mar 3, 2006
Pharmaceutical Business Review ...or refractory acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), high-risk myelodysplastic syndrome (MDS) and ...
Telik Initiates Early Study of Blood Disorder Tablet Feb 23, 2006
International News Service, ...phase I-IIa clinical study to evaluate the tolerability and pharmcokinetics of its Telintra Tablets in patients with the blood disorder myelodysplastic syndrome ...
Surgeon to get cut in 'Grey's' Feb 20, 2006
Detroit Free Press, By the JP McCarthy Fund of the Community Foundation for Southeastern Michigan, $150,000 in grants to fund research in myelodysplastic syndrome and other ...
NCCN Announces Important Updates to Myelodysplastic Syndromes ... Feb 23, 2006
Genetic Engineering News, The NCCN expert panel recommends lenolidamide (Revlimid, Celgene) for the treatment of patients with myelodysplastic syndrome who have an abnormality on part ...
Topotecan/Cytarabine Regimen May Be Effective Alternative for MDS Feb 22, 2006
Cancer Consultants (press release), Long-term follow-up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome. Cancer. ...
Bioenvision to Host Conference Call Following Positive Opinion of ... Feb 23, 2006
Genetic Engineering News, In addition, clofarabine is in clinical development for the treatment of myelodysplastic syndrome (MDS), chronic lymphocytic leukemia (CLL), chronic myeloid ...
Bioenvision to Host Conference Call Following Positive Opinion of ... Feb 23, 2006
Finanzen.net, In addition, clofarabine is in clinical development for thetreatment of myelodysplastic syndrome (MDS), chronic lymphocyticleukemia (CLL), chronic myeloid ...
INNOVIVE Pharmaceuticals Announces Scientific Advisory Board ... Feb 15, 2006
TMCnet Dr. List is an internationally recognized investigator in the biology and treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). ...
Matthew's Journey: Following the road less traveled Feb 19, 2006
Appleton Post Crescent, An option Morrell chose was a recently Food and Drug Administration-approved drug called Azacitidine, used to treat myelodysplastic syndrome, a blood disorder. ...
St. Landry sheriff decides not to run for re-election Feb 11, 2006
2TheAdvocate, Laura Balthazar, chief criminal and civil deputy, said Zerangue has been undergoing treatments for myelodysplastic syndrome, or MDS, and wants to spend more ...
FDA Approves New Treatment for Myelodysplastic Syndrome (MDS) Dec 28, 2005
Community Dispatch (press release) Food and Drug Administration (FDA) has approved the drug Revlimid (lenalidomide) for the treatment of patients with a subtype of Myelodysplastic Syndrome (MDS ...
FDA Approves New Treatment for Myelodysplastic Syndrome Dec 28, 2005
DG News Food and Drug Administration (FDA) has approved the drug Revlimid (lenalidomide) for the treatment of patients with a subtype of myelodysplastic syndrome (MDS ...
Revlimid Approved For Treatment Of Myelodysplastic Syndrome (MDS) ... Dec 29, 2005
MedIndia, A new drug treatment, Revlimid for treatment of myelodysplastic syndrome (MDS), a rare blood disorder has been approved by the Food and Drug Administration (FDA ...
Myelodysplastic syndrome: improvements in hemoglobin levels and ... Jan 8, 2006
Xagena.it, ...of Aranesp ( Darbepoetin alfa ) administered every three weeks to treat anemia in patients with a bone marrow disorder known as myelodysplastic syndrome ( MDS ...
Vion, Spectrum advance cancer candidates Jan 23, 2006
Monsters and Critics.com, ...is also conducting trials of Cloretazine in elderly patients with AML who have not previously been treated, high-risk myelodysplastic syndrome, brain tumors ...
Xanthus Strengthens Patent Estate of Xanafide(TM) for Treatment of ... Jan 24, 2006
PR Newswire (press release), Secondary AML refers to those patients who have developed AML based on an antecedent condition, either myelodysplastic syndrome or prior regimens of ...
ChemGenex Granted US Patent on Ceflatonin(R)'s Use for Treatment ... Jan 17, 2006
Yahoo! News (press release) Ceflatonin is currently being evaluated in chronic myeloid leukemia (CML), myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). ...
ChemGenex Granted US Patent on Ceflatonin(R)'s Use for Treatment ... Jan 17, 2006
PR Newswire (press release), ...but also for potential use in solid tumors." Ceflatonin is currently being evaluated in chronic myeloid leukemia (CML), myelodysplastic syndrome (MDS) and ...
New treatment sanctioned for MDS Jan 13, 2006
Health24.com, The Celgene Corp. drug Revlimid (lenalidomide) has been approved to treat a certain form of Myelodysplastic Syndrome (MDS), a bone marrow abnormality. ...
New Drug for Some Myelodysplastic Syndromes Dec 29, 2005
ACS News Center, The US Food and Drug Administration has approved the drug Revlimid (lenalidomide) for people with a certain type of myelodysplastic syndrome, a bone marrow ...
Rock/jazz interface a natural for Brecker Jan 20, 2006
Indianapolis Star, ...turn to the health of his younger brother and frequent collaborator, tenor saxophonist Michael, who is seriously ill with myelodysplastic syndrome (MDS), a life ...
New Treatment Sanctioned for Bone Marrow Disorder Dec 29, 2005
Forbes ...drug Revlimid (lenalidomide) has been approved by the US Food and Drug Administration to treat a certain form of Myelodysplastic Syndrome (MDS), a bone marrow ...
FDA Grants REVLIMID(R) NDA Approval Dec 27, 2005
Yahoo! News (press release) Chromosomal (cytogenetic) abnormalities are detected in more than half of patients with myelodysplastic syndrome (MDS), and involve a deletion in all or part ...
FDA approves drug for rare blood disease Dec 29, 2005
United Press International Celgene Corp. of Summit, NJ, is distributing lenalidomide as Revlimid for treatment of patients with one type of Myelodysplastic Syndrome. ...
EVERY DAY IS A BLESSING NOW THAT I'M HOME Dec 28, 2005
Glasgow Daily Record, ...sees them regularly. Mike was admitted to St George's Hospital in London last January with myelodysplastic syndrome. The condition ...
Testing in tribute to 11-time GRAMMY winner Michael Brecker Jan 12, 2006
Jazz-Quad, ...the recipient of an experimental half-matching blood stem cell (bone marrow) transplant to combat his affliction with myelodysplastic syndrome, a cancer-like ...
Innovive acquires rights to cancer immunotherapeutic Jan 11, 2006
Pharmaceutical Business Review ...phase I trials in the first half of 2006 to study the compound in the treatment of acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), non small ...
FDA Grants REVLIMID(R) NDA Approval Dec 27, 2005
PR Newswire (press release), Deletion 5q Chromosomal Abnormality Chromosomal (cytogenetic) abnormalities are detected in more than half of patients with myelodysplastic syndrome (MDS), and ...
FDA approves REVLIMID for MDS Dec 29, 2005
Cancerfacts.com, ...developed by Celgene Corporation was approved for the treatment of patients with one of a family of blood disorders, called myelodysplastic syndrome, or MDS. ...
New Drug Offers Hope To MDS Patients Jan 4, 2006
Pittsburgh Channel.com, Snyder suffers from myelodysplastic syndrome -- or MDS -- a group of deadly blood disorders caused when bone marrow makes abnormal blood cells. ...
Moffitt doctor leads study for drug to treat blood disorder Dec 29, 2005
Tampa Bay Business Journal, Revlimid is designed to treat patients with myelodysplastic syndrome (MDS), which can progress to become leukemia. FDA approval ...
Business news in brief from around New Jersey Dec 28, 2005
Newsday, ...therapy medication Revlimid, a drug used to treat patients with transfusion-dependent anemia due to the bone marrow disease myelodysplastic syndrome, or MDS. ...
FDA OKs Celgene’s Revlimid Dec 28, 2005
Red Herring, ...agency this week. The drug will help patients with myelodysplastic syndrome (MDS), who require frequent transfusions. Celgene says ...
Revlimid OK'd for Rare Blood Disorder Dec 28, 2005
FOX News The FDA has approved a new drug called Revlimid to treat a type of the rare blood disorder, myelodysplastic syndrome (MDS), which can progress to become ...
FDA Approves Drug For Rare Bone Marrow Disorders Dec 28, 2005
Jackson Channel.com, WASHINGTON -- A drug has been approved to treat anemia in people who suffer from rare bone marrow disorders known as myelodysplastic syndrome, or MDS. ...
Thalidomide Analog Approved for MDS Dec 28, 2005
MedPage Today, ...today it has approved Revlimid (lenalidomide), a Thalomid (thalidomide) analog, for the treatment of a cytogenetic subtype of myelodysplastic syndrome (MDS). ...
Revlimid OK'd for Rare Blood Disorder Dec 28, 2005
WebMD 28, 2005 -- The FDA has approved a new drug called Revlimid to treat a type of the rare blood disorder, myelodysplastic syndrome (MDS), which can progress to ...
Celgene "neutral" Dec 28, 2005
New Ratings ...morning, the analysts mention that the company has recently indicated that the FDA has approved Revlimid for patients with 5q- myelodysplastic syndrome (MDS). ...
Celgene Cuts Profit Outlook; CEO to Retire Dec 28, 2005
Smartmoney.com The drug is designed to reduce or eliminate the need for drug transfusions in patients with anemia caused by certain types of myelodysplastic syndrome. ...
Telik Announces Presentation and Webcast at JPMorgan Healthcare ... Jan 5, 2006
PharmaLive.com (press release), ...cancer. A second drug development candidate, TELINTRA(TM) (TLK199), is in Phase 2 clinical development in myelodysplastic syndrome. ...
Stem Cell Research - Changing Wishes to Possibilities and ... Jan 6, 2006
MedIndia, ...malignancies’ (chronic myeloid leukemia (CML), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), aplastic ...
INNOVIVE Pharmaceuticals Licenses WT1 Peptide Cancer ... Jan 9, 2006
Genetic Engineering News, ...in the first half of 2006 to study the immunotherapeutic (INNO-305) in the treatment of acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), non ...
Biotech Racks Up Another Impressive Quarter to Close Year in ... Jan 3, 2006
PR Newswire (press release), Celgene (CELG) who received FDA approval of Revlimid, its second-generation version of Thalidomide, as a treatment for patients with myelodysplastic syndrome. ...
Voelz Chandler: Two 'paint' broader pictures Jan 5, 2006
Rocky Mountain News, O'Connell was diagnosed last month with myelodysplastic syndrome (MDS), which he describes as a rare malignant disease of the bone marrow. ...
New drug helps people with form of blood cancer Jan 3, 2006
Indianapolis Star, ...transfusions. Now a new once-a-day drug may free people with myelodysplastic syndrome, or MDS, from their dependence on transfusions. ...
Family rallies to help mom fight rare disease Dec 27, 2005
Daytona Beach News-Journal, ...diagnosis. She was suffering from three rare diseases -- Myeloproliferative disorder, Myelodysplastic syndrome and myelofibrosis. ...
Drug increases hemoglobin in Myelodysplastic Syndrome Dec 13, 2005
MedIndia, Patients with Bone marrow disorder Myelodysplastic Syndrome (MDS), treated with 500 mcg of Aranesp (Darbepoetin alfa) for every three weeks found to improve ...
Myelodysplastic Syndrome - An Underserved Population Offers ... Nov 22, 2005
Genetic Engineering News, Research and Markets (http://www.researchandmarkets.com/reports/c28151) has announced the addition of Myelodysplastic Syndrome - An Underserved Population ...
Myelodysplastic Syndrome - An Underserved Population Offers ... Nov 22, 2005
PharmaLive.com (press release), Nov 22, 2005 - Research and Markets (http://www.researchandmarkets.com/reports/c28151) has announced the addition of Myelodysplastic Syndrome - An Underserved ...
Darbepoetin Alfa (Aranesp) Data Suggests Major Response in Anemic ... Dec 16, 2005
DG News ...alfa (Aranesp) 500 mcg taken Q3W appears to be well tolerated and capable of increasing hemoglobin (Hb) levels in patients with myelodysplastic syndrome (MDS). ...
Vietnam vets die of cancers Dec 20, 2005
Stuff.co.nz, Almost exactly two years ago he had told a parliamentary select committee that he had just contracted yet another cancer – myelodysplastic syndrome, or MDS ...
Updated Interim Aranesp(R) Phase 2 Data Suggest Major Response in ... Dec 11, 2005
Business Wire (press release), ...of Aranesp(R) (darbepoetin alfa) administered every three weeks to treat anemia in patients with a bone marrow disorder known as myelodysplastic syndrome (MDS ...
Breast Cancer Treatment Dec 16, 2005
Food Consumer, Smith RE, Bryant J, DeCillis A, et al.: Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable ...
Dacogen(TM) (Decitabine) Injection Data Presented at American ... Dec 12, 2005
Genetic Engineering News, Session Monday, December 12, 2005, 2:45 PM Abstract Number: 790 CpG Island Methylation Is a Poor Prognostic Factors in Myelodysplastic Syndrome Patients and Is ...
ChemGenex Reports Compelling Phase 2 Data Published In Leading ... Dec 11, 2005
PR Newswire (press release), The second study, a small Phase 2 study of HHT in 9 myelodysplastic syndrome (MDS) patients showed positive results after the first cycle of treatment and met ...
Advances in Radiotherapy Show Benefit for High-Risk Elderly ... Dec 12, 2005
PR Newswire (press release), 12 /PRNewswire/ -- Elderly patients with advanced acute myeloid leukemia, high-risk myelodysplastic syndrome, or relapsed/refractory non-Hodgkin lymphoma ...
Telik's TELINTRA Demonstrates Positive, Clinically Significant ... Dec 11, 2005
Yahoo! News (press release) ...(Nasdaq: TELK - News) reported positive clinical results from a multicenter Phase 2 trial of TELINTRA(TM) in patients with myelodysplastic syndrome (MDS). ...
Source: Quest Diagnostics Incorporated Dec 9, 2005
Yahoo! News (press release) Abstract #2769] Differences in Histone Acetylation Levels in CD34+ Cells between Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS): Correlation ...
'Targeted' cancer treatment effective in older patients Dec 13, 2005
USA Today His team focused on patients 50 and older who had either acute myeloid leukemia or high-risk myelodysplastic syndrome, a condition that often leads to cancer. ...
Cyclacel and Xcyte Therapies Combine to Form International ... Dec 15, 2005
PharmaLive.com (press release), ...a Phase Ib clinical trial of sapacitabine (CYC682) at a leading US cancer center in patients with advanced leukemias and myelodysplastic syndrome, expected in ...
Advances in Radiotherapy Show Benefit for High-Risk Elderly ... Dec 12, 2005
PharmaLive.com (press release), ATLANTA, December 12, 2005 /PRNewswire/ -- Elderly patients with advanced acute myeloid leukemia, high-risk myelodysplastic syndrome, or relapsed/refractory non ...
Tositumomab May Help Elderly with Non-Hodgkin Lymphoma: Presented ... Dec 15, 2005
DG News Elderly patients with advanced acute myeloid leukemia, high-risk myelodysplastic syndrome, or relapsed/refractory non-Hodgkin lymphoma (NHL) generally do not ...
Interim aranesp data suggest major response in anemic patients ... Dec 12, 2005
EurekAlert (press release), ...mcg of Aranesp darbepoetin alfa) administered every three weeks to treat anemia in patients with a bone marrow disorder known as myelodysplastic syndrome (MDS ...
MethylGene Reports Encouraging Preliminary Clinical Results for ... Dec 8, 2005
CCNMatthews (press release), ...additional preliminary and interim clinical data for seven patients with refractory acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS) treated ...
Schering-Plough Media Alert: Data on Schering-Plough Anti ... Dec 13, 2005
PR Newswire (press release), Posaconazole (POS) vs Standard Azoles as Antifungal Prophylaxis in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS): Impact on ...
Aranesp® Effective in Low and Intermediate Risk Myelodysplastic ... Dec 7, 2005
Cancer Consultants (press release), ...darbepoetin alfa) is as effective as Procrit® (epoetin alfa) for the treatment of patients with low and intermediate risk myelodysplastic syndrome (MDS). ...
Azacitidine (Vidaza) Is First Drug to Show Survival Benefit in ... Dec 12, 2005
DG News ...[Presentation title: Azacitidine Prolongs Survival and Time to AML Transformation in High-Risk Myelodysplastic Syndrome (MDS) Patients greater than or equal to ...
Bone marrow drive gives Marine hope Dec 2, 2005
Marines.com Gustavo Aleman Jr., 3rd Recruit Training Battalion administrative chief, was diagnosed with myelodysplastic syndrome May 2004 in Fallujah, Iraq, during a ...
Dose-Dense Chemotherapy Safe and Effective—Particularly for ... Dec 13, 2005
Cancer Consultants (press release), ...treatment groups. Risk of acute myeloid leukemia or myelodysplastic syndrome was similar (less than 1%) in each treatment group. The ...
New Study Shows NOXAFIL(R) (Posaconazole) Oral Suspension ... Dec 12, 2005
PR Newswire (press release), ...azoles for the prevention of IFIs in patients with a new diagnosis or first relapse of acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS) who ...
Vion Presents Cloretazine(R) Data at ASH Annual Meeting Dec 12, 2005
PR Newswire (press release), Trials of Cloretazine(R) as a single agent in acute myeloid leukemia and high-risk myelodysplastic syndrome, adult and pediatric brain tumors, small cell lung ...
Faye Smith dies at 72 Dec 13, 2005
Huntington Herald Dispatch, ...into the ministry, the woman who also was First Lady of Fifth Avenue Baptist, died Sunday in Huntington at the age of 72 of Myelodysplastic Syndrome, a blood ...
'I'm not interested in quality of life' Dec 7, 2005
Guardian Unlimited, Even during the last nine months of her life, once she had been diagnosed with myelodysplastic syndrome or MDS, a particularly virulent blood cancer, she ...
Bake sale benefits cancer patient Dec 9, 2005
Ames Daily Tribune, Earlier this year, Liam, who will turn 4 on Dec. 18, was diagnosed with Myelodysplastic Syndrome, a cancerous blood condition similar to leukemia. ...
Top Advances in Cancer Treatment for 2005 Chosen by Oncologists Dec 2, 2005
SeniorJournal.com, ...cancer. 7. A new treatment for myelodysplastic syndrome (MDS) reduces genetic abnormalities and the need for blood transfusions. The ...
MGI Pharma Seen Meeting 2005 Guidance For Aloxi Nov 29, 2005
Forbes Zhang noted the stock could see near-term catalysts for experimental sedative Aquavan as well as Dacogen, a treatment for myelodysplastic syndrome (MDS), a ...
BMS' dasatinib expected to rival Gleevec Nov 21, 2005
Science Daily (press release) Decision Resources said this drug is pre-registered in the United States and Europe for myelodysplastic syndrome, although it is not yet approved by any ...
Telik Announces Presentation at Lazard Capital Markets Life ... Nov 22, 2005
PR Newswire (press release), ...cancer. A second drug development candidate, TELINTRA(TM) (TLK199), is in Phase 2 clinical development in myelodysplastic syndrome. ...
Illness as More Than Metaphor Dec 3, 2005
New York Times, Even during the last nine months of her life, after she was discovered to have myelodysplastic syndrome, or MDS, a particularly virulent blood cancer, she ...
Biotech Field Shows New Life Nov 18, 2005
Investor's Business Daily (subscription) One hot biotech company, Celgene, (CELG) is working on a treatment for multiple myeloma and myelodysplastic syndrome — diseases whose obscurity puts them on ...
Myelodysplastic Syndrome - An underserved population offers ... Oct 17, 2005
Pharmaceutical Business Review SuperGen/MGI Pharma's Dacogen and Celgene's Revlimid are in pre-registration for treatment of myelodysplastic syndrome (MDS). However ...
Medical Breakthrough - Kidney Transplant Recipient Survives ... Nov 12, 2005
MedIndia, ...years ago. Two years later, doctors discovered he also had a stem cell disease called myelodysplastic syndrome (MDS). According ...
Structure of the Hematological Cancer Market and Its Perspectives Nov 3, 2005
Business Wire (press release), Promising candidates include Celgene's Revlimid, a thalidomide analog in Phase III for myelodysplastic syndrome and multiple myeloma, and Millennium ...
UPDATE 1-US approves Novartis drug to treat excess iron Nov 2, 2005
Reuters Patients with sickle cell anemia, myelodysplastic syndrome or other blood disorders regularly undergo blood transfusions and can experience iron overload, a ...
Celgene Lifts Revenue Objective Nov 3, 2005
TheStreet.com ...drug advisory committee recommended that the agency approve Celgene's drug Revlimid for a specific group of patients with myelodysplastic syndrome, a type of ...
Newsmakers | Shyamalan's sense: Movies' magic should be introduced ... Oct 30, 2005
Philadelphia Inquirer, Brecker, 56, who lives in Hastings-on-Hudson, NY, suffers from myelodysplastic syndrome, in which bone marrow does not produce enough blood cells. ...
Biotech Has October Blues Nov 1, 2005
PR Newswire (press release), ...(TELK) also plummeted 9% in October. The company is proceeding with a study of an oral formulation of Telintra in patients with myelodysplastic syndrome. ...
University of Virginia Hillel Hosts Bone-Marrow Drive Oct 17, 2005
Hillel.org, ...in a blood marrow donor drive on behalf of renowned jazz saxophonist, Michael Brecker, who has been diagnosed with Myelodysplastic Syndrome (MDS), a bone ...
Risk of Second Cancers After Hodgkin’s Lymphoma Is Similar ... Nov 2, 2005
Cancer Consultants (press release), ...cancers were lung (31 cases), breast (18 cases), gastrointestinal (16 cases), and treatment-related acute myeloid leukemia or myelodysplastic syndrome (18 cases ...
Chronic Exposure To Benzene May Result In Dysplasia Oct 31, 2005
MedIndia, Myelodysplastic syndrome is a heterogeneous group of diseases characterized by ineffective hematopoiesis, dysplasia in one or more hematopoietic lineages ...
Vion Holds Annual Meeting and Provides Clinical and Preclinical ... Oct 25, 2005
PR Newswire (press release), II single agent trial, we are encouraged as well with its potential for use in the treatment of poor-risk AML and high- risk myelodysplastic syndrome (MDS) in ...
Xanthus Initiates a Phase 2 Study Of Xanafide in Combination with ... Oct 20, 2005
Yahoo! News (press release) ...at multiple centers in North America and is expected to enroll up to 60 patients with secondary AML (patients with antecedent myelodysplastic syndrome or prior ...
Ronnie Polaneczky | Suck it up and, maybe, save a life Oct 25, 2005
Philadelphia Daily News, 56, was still high on the applause that his new album, "Wide Angles," was generating when he was diagnosed in 2004 with myelodysplastic syndrome, a cancer that ...
Marine fighting two wars--time and leukemia Oct 13, 2005
North Channel Sun, Marine Staff Sgt. Gustavo Aleman, a 1993 graduate of North Shore High School, is suffering from myelodysplastic syndrome--a rare form of leukemia. ...
Award-Winning Saxophonist Needs Bone Marrow Transplant Oct 25, 2005
NBC 10.com, Brecker has myelodysplastic syndrome -- a bone marrow disorder that develops before leukemia and often morphs into acute myelogenous leukemia. ...
The myelodysplastic syndromes (MDS, formerly known as "preleukemia") are a diverse collection of haematological conditions united by ineffective production of blood cells. Anemia requiring chronic blood transfusion is frequently present.
|
|
|
